Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adenosine for myocardial protection during cardiopulmonary bypass surgery
RBR-6q3kyykPhase 4Not yet recruiting
- Sponsor
- Hospital Nossa Senhora da Conceição
- Start
- Feb 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in Myocardial injury comparing Adenosine with Placebo (2 arms). Planned start Feb 2026; status: not yet recruiting.
02
Drugs
adenosine
03
Conditions
Myocardial injury
Beyond the preview
Go deeper on RBR-6q3kyyk.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-6q3kyyk.